The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice.
GLP-1 藥物 semaglutide 和 tirzepatide 不會改變 5XFAD 和 APP/PS1 小鼠的疾病相關病理、行為或認知功能。
Mol Metab 2024-08-31
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice.
Semaglutide和empagliflozin對肥胖小鼠認知功能和海馬磷蛋白質組學的影響。
Front Pharmacol 2023-04-04
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway.
Semaglutide透過GLP-1R/SIRT1/GLUT4途徑改善3xTg小鼠模型阿茲海默症的認知和葡萄糖代謝功能。
Neuropharmacology 2023-10-13
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies.
GLP-1受體激動劑在實驗性阿茲海默症模型中的應用:對預臨床研究的系統性回顧和荟萃分析。
Front Pharmacol 2023-10-03
SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
SGLT2和DPP4抑制劑透過不同機制改善T2D-AD小鼠模型中類似阿茲海默症的病理和認知功能。
Biomed Pharmacother 2023-11-30
Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
Liraglutide與pramlintide在保護高脂飲食-腺苷脫氧核糖核酸大鼠模型中的認知功能損傷方面的比較:對PI3K/AKT/GSK-3β/TTBK1途徑的影響和減少Tau過度磷酸化。
Pflugers Arch 2024-05-07
A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies.
Semaglutide對預臨床動物模型和細胞研究中認知功能影響的系統性回顧。
Int J Mol Sci 2024-05-13
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.
Semaglutide 減輕焦慮和抑鬱樣行為,並通過微生物-腸-大腦軸逆轉 2 型糖尿病小鼠模型中的認知障礙。
J Neuroimmune Pharmacol 2024-07-23